A study on chronic disease management program for users of welfare facilities for persons with disabilities

A study on risk stratification of chronic diseases (hypertension, diabetes, arteriosclerosis) in users of welfare facilities for persons with disabilities and chronic disease management program for high-risk groups - A study on risk stratification of chronic diseases in users of welfare facilities for persons with disabilities and chronic disease management program for high-risk groups

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040388

Enrollment

Registered

2020-05-15

Start date

2020-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nursing

Interventions

One chronic disease management program for users of welfare facilities Biweekly for six months, total twelve times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects are men and women between the ages of 20 and 75, and those with disabilities (neurocognitive disorders, intellectual disability, mental disorders) attending welfare facilities for persons with disabilities and those who have consented to participate in the study

Exclusion criteria

Exclusion criteria: Exclude any of the following cases. Those who cannot communicate Those who cannot answer questions due to disabilities or mental illness Person who did not get consent from the legal representative (family or agent)

Design outcomes

Primary

Measure	Time frame
Achievement rate (diet therapy, exercise therapy, medication compliance, smoking, drinking)	—

Secondary

Measure	Time frame
Blood pressure Complication of heart disease and cerebrovascular disease Blood sugar level (fasting, 2 hours after meal) Development of diabetic complications Measurement of arteriosclerosis Progression of arteriosclerosis weight, BMI, waist circumference Urinalysis (urine sugar) Number of hospitalizations Type and amount of drug QOL scale score (SF-8) Degree of forgetting to take medication Number of visits / rate Social support	—

Measure

Time frame

Blood pressure Complication of heart disease and cerebrovascular disease Blood sugar level (fasting, 2 hours after meal) Development of diabetic complications Measurement of arteriosclerosis Progression of arteriosclerosis weight, BMI, waist circumference Urinalysis (urine sugar) Number of hospitalizations Type and amount of drug QOL scale score (SF-8) Degree of forgetting to take medication Number of visits / rate Social support

—

Countries

Japan

Contacts

Public ContactNozomi Takayama

Hokkaido University Faculty of Health Science

harvester.20101001@gmail.com070-3875-3714

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026